Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
Recruiting · NCT07402473 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer | HER2-positive Early-stage Breast Cancer | Recruiting | Phase 2 | 2026-04-23 | NCT07402473 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rutgers, The State University of New Jersey | 154 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rutgers Cancer Institute | New Brunswick | United States | 41 |
| RWJBarnabas Health - Community Medical Center | Toms River | United States | 9 |
| RWJBarnabas Health - Monmouth Medical Center | Long Branch | United States | 7 |
| RWJBarnabas Health - Newark Beth Israel Medical Center | Newark | United States | 7 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton | Hamilton | United States | 4 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset | Somerville | United States | 1 |
| RWJBarnabas Health - Trinitas Hospital and Comprehensive Cancer Center | Elizabeth | United States | 1 |